← FDA Drug Approvals (Drugs@FDA)

METHOTREXATE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 1999-02-26

Drug application

FDA Application #

ANDA040263

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHOTREXATE SODIUM

Generic name

METHOTREXATE SODIUM

Active ingredients

METHOTREXATE SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

1999-02-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown